Relationship between the 5,10-Methylenetetrahydrofolate
Reductase C677T Gene Polymorphism
and Clinical Manifestation of Coronary Artery Disease

M. G. Spiridonova1, V. A. Stepanov1, V. P. Puzyrev1, and R. S. Karpov2

1 Research Institute of Medical Genetics, Tomsk Scientific Center, Siberian Division, Russian Academy of Medical Sciences,
Tomsk, 634058 Russia; fax: (3822) 22-37-44; e-mail: maria347@mail.ru
2 Institute of Cardiology, Tomsk Scientific Center, Siberian Division, Russian Academy of Medical Sciences, Tomsk, 634058 Russia

Received September 23, 1999

Abstract—Association of the methylenetetrahydrofolate reductase gene (MTHFR) C677T missense mutation
(substitution of cytosine by thymine at position 677) with coronary artery disease (CAD), as well as with blood
levels of various lipoprotein fractions, systolic pressure (SP), diastolic arterial blood pressures (DP), and body
mass index (BMI) in patients with angiographically verified CAD and in a control group was analyzed. The
affected and control subjects did not differ substantially with respect to genotypic and allelic frequencies. The
MTHFR
gene polymorphism was not associated with variation in either total cholesterol (TC), very low-den-
sity-lipoprotein cholesterol (VLDLC), low-density-lipoprotein cholesterol (LDLC), high-density-lipoprotein
cholesterol (HDLC), or triglyceride (TG) levels. SP and DP in subjects with different MTHFR genotypes did
not differ significantly. BMI tended to correlate with the C677T polymorphism of the MTHFR gene (0.05 < P
< 0.1). C677Tmutation frequencies in western Siberia were determined for the first time; they are about the
same as in most European populations.


Pleiades Publishing home page | journal home page | top

If you have any problems with this server, contact webmaster.